Evaluation of the clinical efficacy and safety of clarithromycin in treament of community acquired pneumonia
- Author:
Nguyen Xuan Bich Huyen
- Publication Type:Journal Article
- Keywords:
clarithromycin, pneumonia
- MeSH:
Pneumonia;
Clarithromycin;
Therapeutics;
Pharmaceutical Preparations;
Community-Acquired Infections
- From:Journal Ho Chi Minh Medical
2004;8(1):22-27
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
Clarithromycin had high efficacy in treatment of 39 community acquired pneumonia with low risk factors, including pneumonia 38 patients (50.67%), exacerbation of COPD and asthma 24 patients (32%), and acute bronchitis due to bacteria 13 patients (17.33%), with succesfully rate of 95.65%. The average duration of therapy was 8.56 days and only a few side effects (5.8%), including mainly nausea and diarrhea were observed. Clarithromycin is a safe and effective drug in treatment of community acquired lower respiratory infections
